We use cookies to give you the best possible experience with eirhub.eu. Some are essential for this site to function; others help us understand how you use the site, so we can improve it. We may also use cookies for targeting purposes. Click “Accept all cookies” to proceed as specified, or click “Manage my preferences” to choose the types of cookies you will accept. Cookie policy
Privacy Preference Center
Eirhub and our trusted partners use cookies and similar technologies to access and use your data for the purposes listed below. Please provide your consent for cookie usage on this website. Enable one or more of the cookie types listed below, and then save your preferences. Cookie policy
Manage Consent Preferences
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Active (Inactive)
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Active (Inactive)
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising. Active (Inactive)
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. Always Active

Market Access Pathway for a Schizophrenia Drug

Define a winning commercial model
Define a winning commercial model
Arthur D. Little
The biggest CIS market
Project scope:
  • Market landscape analysis.
  • Pricing & Reimbursement overview.
  • Treatment practices and available infrastructure.
  • Prescribing and distribution channels for LAIs.
  • National Formulary system and stakeholders.
  • Epidemiology and infrastructure study.
  • Analysis of established treatment practices.
  • Understanding the patients' pathways.
Market analysis:
  • Collection of statistical, medical, epidemiological and economic data.
  • Study of the local market of antipsychotic drugs by country's core sales channels: hospital and retail.
  • Analysis of the potential of each sales channel: private, public.
  • Elaboration of the marketing authorization process in the country.
  • Research on the dynamics of LAIs prescription in the country by core regions.
  • Analysis of the unmet need in LAIs in the country.
  • Analysis of pricing requirements when being enlisted into the reimbursement program.
  • Elaboration of the reimbursement authorization process in the country
Treatment practices and available infrastructure:
  • Analysis of the treatment pathway of LAIs in the country.
  • Analysis of treatment practices in inpatient and outpatient settings.
  • Overview of clinical practices in the country concerning the usage/prescribing of LAIs.
  • Understanding a set of established clinical practices regarding the existing treatment preferences using orals and other antipsychotic drugs.
  • Building up a prescribing landscape for LAIs in the country.
  • Identification of major treatment centers in the country and its regions.
  • Identification of product prescribing levels by country regions: national, regional, and province.
Formulary system:
  • Overview of the formulary system in the country.
  • Reviewing formularies at all levels and understanding their impact on the price formation process in the country.
  • Study of formulary listing requirements, and regional differences.
  • Understanding the timing and costs associated with the formulary enlisting process.
  • Identification of the level of formulary influence on clinical practitioners on their prescribing behavior.
Pricing study:
  • The pricing structure for competitors of Target's product in the country.
  • Analysis of pricing structures per each sales channel: private, public.
  • A complex, detailed, stage-by-stage roadmap of bringing an innovative LAI into the biggest CIS market.
  • Expert interviews with experts, practicing HCPs, and KOLs.
  • Overview of the local treatment landscape in schizophrenia.


Yevgen Brovko
Co-founder, Market Access Partner (Pharmac/Biopharma, MedTech, Digital Health)
our Brochure